IFITM3 promotes cancer cell proliferation, migration, and metastasis through the TGFβ signaling pathway in prostate cancer cells [49] and facilitates type 2 helper T cell differentiation [50] as well as tumor-associated antigen presentation [51]. This evidence concerns the gene TGFB1 and Familial prostate cancer.